Asian patients with de novo metastatic prostate cancer have better survival outcomes than White patients with the same condition, regardless of the type of treatment they received, according to a study published in the Journal of the National Comprehensive Cancer Network. For this study, Dr. Xudong Ni and colleagues analyzed patient data from three large databases: the LATITUDE trial (764 patients), the SEER database (15,476 patients), and the National Cancer Database (10,366 patients). The study included 26,286 patients, of whom 2,781 were Asian and 23,505 were White. ...
Disparities in Prostate Cancer
Advertisement
Approximately 30% - 40% of the variation in PSA is "noise" that isn't cancerous but determined by genetics.
Black individuals are more likely to believe videos about prostate cancer when Black physicians or patients present it.
Men with a BMI of 30 or higher were less likely to screen positive for either the PSA test or DRE.
American Indian and Alaska Native men are less likely to get PSA testing and DREs for prostate cancer screening.
Studies have found that men of African ancestry die from prostate cancer more frequently than others.
An increase in advanced-stage cancer diagnoses with a decline in PSA testing.
Researchers found 9 novel prostate cancer risk genetic loci, 7 of which were more specific to men of African ancestry.
"Waiting for urinary symptoms may mean missing opportunities to catch (prostate cancer) when it's treatable."
Advertisement
Expert Interviews
Dr. Julia Riley sits down with two investigators to discuss a study related to distance as a barrier in psoriasis trials.
Maimah Karmo talks about Tigerlily Foundation’s partnership with GSK, Living Legacy and Pharma accountability.
Maimah Karmo, CEO of Tigerlily Foundation on her cancer journey and breast cancer clinical trial awareness and education.
Clinical pharmacist Thomas So, PharmD, discusses the prevelence of these conditions and therapies available to treat them.
Dr. Adam Friedman talks about a telemedicine program designed to improve dermatologic medical care in underserved areas.
Dr. Elle de Moll, a Connecticut-based dermatologist, discusses the health disparities communities of color face is psoriasis.
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
